SynthesisNeurosurgical review2026
Long-term outcomes of ventricular entry in high grade glioma resection: A meta-Analysis and meta regression.
Synthesis in Neurosurgical review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Primary diffuse leptomeningeal glioblastoma: Report of two cases.Surgical neurology international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ventricular entry (VE) in high-grade gliomas (HGGs) has been hypothesized to predispose patients to adverse events and poor outcomes; however, the extent remains unclear. This study aimed to systematically evaluate the impact of VE in patients with HGG. A PROSPERO-registered (CRD420251053281) systematic search was conducted in the ScienceDirect, Scopus, PubMed, Google Scholar, and Cochrane databases to identify longitudinal studies up to June 2025. Primary outcomes included leptomeningeal dissemination (LMD), distant parenchymal recurrence (DPR), and hydrocephalus. Additionally, survival analysis with Kaplan-Meier curve and meta-regression were conducted to assess survival patterns and identify study-level moderators contributing to heterogeneity. Seventeen studies involving 4,086 participants (mean age 57.24 ± 11.21 years; 52.26% male) met the inclusion criteria. VE was significantly associated with increased risks of LMD (RR 2.23; 95% CI 1.61-3.11; p < 0.001) and hydrocephalus (RR 3.57; 95% CI 1.88-6.80; p < 0.001), but not DPR in the overall analysis. Survival analysis revealed that VE is associated with increased mortality (HR 1.12; 95% CI 1.03-1.21) up to 84 months. Meta-regression revealed that prior treatment was inversely associated with LMD, whereas increasing age, male sex, glioblastoma histology, and receipt of chemotherapy or radiotherapy were positively associated with DPR. In contrast, non-methylated status and radiotherapy were inversely associated with hydrocephalus. VE in HGGs may be associated with increased risks of LMD, hydrocephalus, and reduced survival. However, these associations should be regarded as provisional.
Indexed as
Identifiers
41619073What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.